Free reference · not medical advice

Peptide FDA status tracker

Which peptides are FDA-approved drugs, which are still in clinical trials, and which are research-only. A conservative, cited summary — always verify current status with the FDA.

5
FDA approved
4
In clinical trials
59
Not FDA approved

  • Liraglutide

    Victoza · Saxenda

    FDA approved

    GLP-1 agonist approved for type 2 diabetes and weight management.

  • PT-141 (Bremelanotide)

    Vyleesi

    FDA approved

    Approved for hypoactive sexual desire disorder in premenopausal women.

  • Semaglutide

    Ozempic · Wegovy · Rybelsus

    FDA approved

    Approved for type 2 diabetes and chronic weight management.

    Source ↗

  • Tesamorelin

    Egrifta

    FDA approved

    GHRH analog approved to reduce excess visceral fat in HIV-associated lipodystrophy.

  • Tirzepatide

    Mounjaro · Zepbound

    FDA approved

    GIP/GLP-1 dual agonist approved for type 2 diabetes and weight management.

    Source ↗

  • Cagrilintide

    Phase 3 (with semaglutide = CagriSema)

    In clinical trials

    Novo Nordisk amylin analog, studied mainly combined with semaglutide (CagriSema).

    Latest: REDEFINE 1: 22.7% weight loss at 68 weeks. Novo filed an FDA NDA for CagriSema (Dec 2025); decision anticipated late 2026.

    Source ↗

  • Mazdutide

    Approved in China · not FDA

    In clinical trials

    Innovent/Lilly GLP-1/glucagon dual agonist. Approved in China (GLORY-1) — NOT FDA-approved; no US approval.

    Latest: GLORY-2 (Nov 2025): up to ~20.1% weight loss at 60 weeks. China-approved; US/FDA status unchanged (research-only in the US).

    Source ↗

  • Retatrutide

    Phase 3 (TRIUMPH)

    In clinical trials

    Eli Lilly triple GIP/GLP-1/glucagon agonist in late-stage weight-management trials. Not FDA-submitted yet.

    Latest: TRIUMPH-1 (May 2026): ~28.3% average weight loss at 80 weeks. Lilly NDA submission expected Q4 2026–Q1 2027.

    Source ↗

  • Survodutide

    Phase 3 (SYNCHRONIZE)

    In clinical trials

    Boehringer Ingelheim glucagon/GLP-1 dual agonist for obesity and MASH (FDA Breakthrough Therapy in MASH).

    Latest: SYNCHRONIZE-1 (Apr 2026): ~16.6% weight loss at 76 weeks; presented at ADA 2026 / published in NEJM.

    Source ↗

  • 5-Amino-1MQ

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Abaloparatide

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Adipotide

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • AHK-Cu

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • AOD-9604

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • ARA-290

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • BPC-157

    Not FDA approved

    Not FDA approved. The FDA has placed it in a category difficult to compound; research use only.

  • Bronchogen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Cartalax

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Cerebrolysin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Chonluten

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • CJC-1295 (no DAC)

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • CJC-1295 (with DAC)

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Cortagen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Crystagen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • DSIP

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Epitalon

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Follistatin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • FOXO4-DRI

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • GHK-Cu

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • GHRP-2

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • GHRP-6

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Gonadorelin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Hexarelin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Humanin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • IGF-1 LR3

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Ipamorelin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Kisspeptin-10

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • KPV

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Livagen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • LL-37

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Melanotan I

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Melanotan-2

    Not FDA approved

    Not FDA approved. The FDA has warned against unapproved 'tanning' peptides.

  • MK-677 (Ibutamoren)

    Not FDA approved

    Investigated historically but never FDA approved; sold for research only.

  • MOTS-c

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Ovagen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Oxytocin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Pancragen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • PE-22-28

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Pinealon

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • PNC-27

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Prostamax

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Selank

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Semax

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Sermorelin

    Not FDA approved

    A branded product (Geref) was previously approved but withdrawn; not currently an FDA-approved drug.

  • SNAP-8

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • SS-31 (Elamipretide)

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • TB-500

    Not FDA approved

    Thymosin Beta-4 fragment. Not FDA approved for human use; research only.

  • TB-500 Fragment

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Teriparatide

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Testagen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Thymalin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Thymogen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Thymosin Alpha-1

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Thymulin

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Vesilute

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Vesugen

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • Vilon

    Not FDA approved

    Not FDA approved for human use; sold for research only.

  • VIP

    Not FDA approved

    Not FDA approved for human use; sold for research only.

FDA approved: Approved by the FDA for one or more indications (as a specific branded drug).

In clinical trials: Not approved, but in active clinical trials in the US. Availability is limited to studies.

Not FDA approved: Not approved by the FDA. Sold for research only — not established as safe or effective for human use.

Informational only — verify with the FDA.

Regulatory status changes over time and varies by indication and formulation. This summary is curated for general reference and is not legal or medical advice. Approved status refers to specific branded drug products, not to bulk or compounded peptide material.

Peptide FDA Approval Status Tracker · PepStash